The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families-Reference-Cited by-同舟云学术

The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families

Published:2024-02 Issue: Volume:73 Page:103611
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Schreurs Maartje A.C.,Ramón y Cajal Teresa,Adank Muriel A.,Collée J. Margriet,Hollestelle Antoinette,van Rooij Jeroen,Schmidt Marjanka K.,Hooning Maartje J.^ORCID

Funder

KWF Kankerbestrijding

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference38 articles.

1. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations;Meijers-Heijboer;Nat Genet,2002

2. CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies;Consortium;Am J Hum Genet,2004

3. CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls;Weischer;J Clin Oncol,2008

4. Excess breast cancer risk in first degree relatives of CHEK2*1100delC positive familial breast cancer cases;Adank;Eur J Cancer,2013

5. Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study;Zhang;Cancer Res,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families;Genetics in Medicine;2024-09

2. A contemporary review of breast cancer risk factors and the role of artificial intelligence;Frontiers in Oncology;2024-04-18